Floatz logo

Metformin

Familial Adenomatous Polyposis

Yonsei UniversitySmall moleculePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Familial Adenomatous Polyposis cohort.

Asset / SponsorPhaseRating
Eicosapentanoic Acid
S.L.A. Pharma AG
Phase 3BB
Eflornithine
Cancer Prevention Pharmaceuticals, Inc.
Phase 3BB
Dfn-15
Yonsei University
Phase 3BB
Erythromycin
michal roll
Phase 4BB
Azithromycin
Tel-Aviv Sourasky Medical Center
Phase 4BB

View all 27 →

Same molecule, other indications

Metformin is also rated in:

Metabolism and Nutrition DisorderDormant
A
Indicative ·
82 / 100
View asset →
prediabetes syndromeDormant
A
Indicative ·
81 / 100
View asset →
gestational diabetesDormant
A
Indicative ·
81 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →